A drug with the SMILES CC1(C)[C@@H](O)CC[C@]2(C)C3C(O)C=C4[C@H]5C[C@@](C)(CO)CC[C@]5(C)CC[C@]4(C)[C@]3(C)CC[C@@H]12 has a human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM of 15.393\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CC1(C)[C@@H](O)CC[C@]2(C)C3C(O)C=C4[C@H]5C[C@@](C)(CO)CC[C@]5(C)CC[C@]4(C)[C@]3(C)CC[C@@H]12
CC1(C)[C@@H](O)CC[C@]2(C)C3C(O)C=C4[C@H]5C[C@@](C)(CO)CC[C@]5(C)CC[C@]4(C)[C@]3(C)CC[C@@H]12
(3S,4aR,6aR,6bR,8aS,11S,12aS,14bS)-11-(hydroxymethyl)-4,4,6a,6b,8a,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-3,14-diol